.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The PRORATA trial evaluated a procalcitonin-guided strategy for starting and stopping antibiotics in critically ill adults with suspected bacterial infection. The goal was to reduce unnecessary antimicrobial exposure without increasing mortality or recurrent infection. The trial showed that biomarker-guided treatment could reduce antibiotic exposure while maintaining comparable clinical outcomes. Procalcitonin was used within a predefined algorithm rather than interpreted in isolation. This is important for modern antimicrobial stewardship because prolonged antibiotic courses can drive toxicity and selection of multidrug-resistant organisms. At the same time, biomarkers are imperfect and should not be allowed to override obvious clinical evidence of ongoing infection or inadequate source control. CritiCARE 2026 explicitly discusses antibiotic stewardship, procalcitonin and antibiotic dosing in AKI, making this study highly relevant. For HCPs, the practical use of procalcitonin is as a structured aid to reassess whether continued antibiotics remain necessary. The strongest approach combines the trajectory of the patient, microbiology, source-control status, organ function and biomarker trends. The trial therefore supports a stewardship mindset: every antibiotic course should have a reassessment plan, an indication for continuation and a stopping decision.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The PRORATA trial evaluated a procalcitonin-guided strategy for starting and stopping antibiotics in critically ill adults with suspected bacterial infection. The goal was to reduce unnecessary antimicrobial exposure without increasing mortality or recurrent infection. The trial showed that biomarker-guided treatment could reduce antibiotic exposure while maintaining comparable clinical outcomes. Procalcitonin was used within a predefined algorithm rather than interpreted in isolation. This is important for modern antimicrobial stewardship because prolonged antibiotic courses can drive toxicity and selection of multidrug-resistant organisms. At the same time, biomarkers are imperfect and should not be allowed to override obvious clinical evidence of ongoing infection or inadequate source control. CritiCARE 2026 explicitly discusses antibiotic stewardship, procalcitonin and antibiotic dosing in AKI, making this study highly relevant. For HCPs, the practical use of procalcitonin is as a structured aid to reassess whether continued antibiotics remain necessary. The strongest approach combines the trajectory of the patient, microbiology, source-control status, organ function and biomarker trends. The trial therefore supports a stewardship mindset: every antibiotic course should have a reassessment plan, an indication for continuation and a stopping decision.
last month
Preclinical findings demonstrate that ginsenoside Ra1 preserves vascular integrity and attenuates multi-organ injury during sepsis by targeting non-muscle myosin heavy chain IIA (NMMHC IIA) and dampening TLR4/NF-κB/NLRP3 inflammatory signaling.
2 days back
An all-printed immunosensing microchip detects urinary sFlt-1 in just 10 minutes with 3.61 pg/mL sensitivity. By leveraging photonic bandgap engineering, this low-cost, cleanroom-free platform provides non-invasive preeclampsia screening, offering substantial benefits for point-of-care obstetric triage.
3 days back
Wearable ultrasound patches are transforming healthcare by shifting medicine from episodic evaluations to continuous monitoring. Discover how flexible acoustic transducers advance cardiovascular tracking, musculoskeletal imaging, neuromodulation, and on-demand closed-loop theranostics.
3 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
Last week
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
Last week
